Diabeloop Adapts Its Self-Learning, Personalized Insulin Automatization Software to Be Used With Insulin Pens PARIS, April 12, 2022 (GLOBE NEWSWIRE) -- Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential of its diabetes technology to enable the integration of...

Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings TOKYO & PARIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Terumo Corporation, a global leader in medical technology, and the French company Diabeloop, a pioneer in therapeutic AI, announced today that...